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Abstract
Background
Frontalis suspension surgery is considered the procedure of choice in cases of blepharopto-
sis. Among all the materials used in this type of surgery, ophthalmic and plastic surgeons
prefer to use autologous Fascia Lata. However, during years, other autogenous and exoge-
nous materials have been introduced.
Objectives
The aim of this study was therefore that of systematically reviewing the functional results
and the rate of complications of different synthetic materials, as compared to autogenous
Fascia Lata. The primaryobjective was to determine the rates of Successful Surgeries
(SSs) of thesematerials. The secondary objective was to assess the onset of complica-
tions. The following materialswere investigated: Fascia Lata, Mersilene, polytetrafluor-
oethylene (PTFE) and Silicon.
Data Source andMethods
Following the Prisma procedure, on January 30th, 2016 we used the following electronic
databases to select the studies: MEDLINE and Scopus.
Results
The search strategy retrieved 48 publications that met the eligibility criteria of the systematic
review. All studies were non-comparative. PTFE (n = 5) showed the best rate of SSs among
thematerials compared (statistically significant). Surgeries performedwith autogenous Fas-
cia Lata (n = 19) had a 87% rate of success those performedwith Mersilene (n = 12)had
92% and those performedwith Silicon (n = 17)88%. PTFE had the best outcome, with 99%
success rate. As for complications, surgeries performedwith PTFE had a higher rate of
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suture infections (1.9%) as compared to Fascia Lata, but lower incidence for all other
complications.
Conclusions
Althoughmost studies were good quality cohort studies, the overall quality of this evidence
should be regarded as low due to their non-comparative design. Our data suggest that
PTFE seems to be the most valid alternativematerial for frontalis suspension surgery, with
low recurrence rates and good cosmetic and functional results.
Introduction
Blepharoptosis is an abnormal low-lying upper eyelid margin with the eye in primary gaze and
represents one of the most challenging problem for plastic and oculoplastic surgeons.
Blepharoptosis can ensue from several congenital or acquired conditions [1] and may cause,
depending on the age at onset, an almost complete obscuration of the visual axis. In addition,
in younger age groups, blepharoptosis is also causing aesthetic concerns, with problems of per-
manent deprivation, amblyopia and bizarre head posture [2]. It is therefore fundamental to
perform a surgery ensuring the best outcome and long–lasting results to the subject affected.
At present, the best surgical practice in cases of ptosis associated with poor levator function
(i.e. levator function<4 mm) is the frontalis suspension surgery. The aim of the procedure is
to create a connection between the frontalis muscle and the tarsal plate, in order to allow the
lid to mobilize in an upward movement when the muscle contracts. Originally describedby
Payrin in 1909 [3] andWright in 1922[4], in 1956 this surgery was further developed by Craw-
ford who introduced the use of autogenous Fascia Lata as the standard sling material in chil-
dren older than three years of age [5].
Nowadays, although autologous Fascia Lata is still the preferred material used for the afore-
mentioned surgery, several other autogenous or exogenous materials have been proposed for
the restoration of the deficit of the levator palpebrae [6].
Thus, in this study we aimed at systematically review the functional results and the rate of
complications of three different synthetic materials introduced in the surgical practice over
years: mersilenemesh, silicon rods and polytetrafluoroethylene (PTFE). Specifically, we com-
pared the results obtained in the surgical practice with these materials to those of autogenous
Fascia Lata, which is still the most preferred and adopted material by ophthalmic and plastic
surgeons in the management of ptosis related to poormuscle function.
Methods
Search strategy, study selection and data extraction
On January 30th 2016, pertinent articles were identified by using the following databases:
MEDLINE and Scopus.
We adopted the following search strategies: (Blepharoptosis) AND (frontalis sling OR fron-
talis suspension OR surgery) AND (mersilene OR polytetrafluoroethylene (PTFE) OR Fascia
Lata OR silicon) from January 1989 to 2016. Other articles were identified by analyzing the
citations reported in the studies found. Papers resulting from the two databases were matched
and duplicates were excluded.
A first screening process for title and abstract was performed by two independent
researchers.
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After that, we adopted the following inclusion criteria: (a) studies where more than 9 surger-
ies were performed and monitored; (b) English written; (c) at least 30 days of follow-up; and
(d) studies reporting at least one outcome rate (recurrence and/or complications).
Subsequently, the full texts of selected studies were evaluated to confirm the adherence to
eligibility criteria. Only cohort studies were considered eligible for inclusion. RandomizedCon-
trolled Trials (RCTs), case studies and other study designs were excluded.
Two independent researchers evaluated the papers and extracted the data. Controversies on
data extractionwere solved by discussion between them, and, in case of disagreement, by the
judgment of a third researcher.
Information selected and definition of outcomemeasures
Information on the year of publication, the country where the studies took place, the sample
size and characteristics (age and gender) was collected.
Information on the cause of blepharoptosis, the material used, the effectiveness of the sur-
geries performed, the rates of specific pathologic conditions arisen after surgery was also
collected.
The first outcome of our search was the rate of Successful Surgeries (SSs), the second out-
come was the Overall Rate of Complications (ORC), and the third the rate of each single com-
plication arisen after surgery. We defined as “SSs” the surgeries not requiring a re-intervention
regardless of the onset of complications, and not leading to relapse or hesitating in hypo-cor-
rection. ORC were defined as the sum of all complications reported in each single study.
Risk of Bias in individual studies
The risk of bias was assessed by the evaluation of the quality of the included studies. Two inde-
pendent researchers assessed the Newcastle-Ottawa score for cohort studies [7].
Summarymeasures
The pooled SSs prevalence for each material was calculated. The pooled prevalence of ORC
and of each single pathologic condition caused by the surgery were also calculated.
Heterogeneity, risk of bias, meta-regressionand data reporting
Statistical heterogeneity was assessed by the Q Cochrane test and I2 test
The model adopted for the statistical analysis was a random-effectmodel.
The pooled prevalence was reported with 95% Confidence Interval (95%CI). Publication
bias was measured by the Begg funnel plot [8]. All the Forest plots and the Begg Funnel plots
are shown in Supplemental electronic files.
Meta-regression analysis was performed in order to assess whether year of publication,
mean age of the sample, the gender distribution, the length of follow-up or the quality of stud-
ies could affect the rate of SSs and ORC. Statistical analyses were performedwith Stat Direct
Software (pooled incidence) and SPSS (meta-regression) Software. Data were reported accord-
ing to the PRISMA protocol [9].
Results
Study selection
The search strategy retrieved 256 records in two different databases. After deduplication and
examination of the titles and abstracts, 152 studies were excluded from the review process (S1
Table). 105 full-text copies of the remaining studies were obtained and subjected to further
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evaluation. 59 of these studies were excluded and the reasons for exclusion were annotated. At
the end of the process, 48 publications meeting the eligibility criteria were selected for review
(Fig 1). The number of studies included for Fascia Lata were 19 [10–28], for Mersilene 12
[29,30,22,31,32,25,33–38], for PTFE 5 [39–41,26,42] and for Silicon 17 [43–52,13,53,54,20,55–
57].
Characteristicsof the included studies and quality assessment
Table 1 shows characteristics of the studies included [15,29,30,32,34–36,38–41,51]. The time
range of the selected studies was 1990[38]-2015[35]. Results of the quality assessment per-
formed through the Ottawa-Newcastle scale are shown in Table 1.
This scale was adopted to evaluate the potential bias within the studies. All the studies
scored 5 points or above. Quality score was included as covariate into the meta-regression to
assess whether quality affected the results of the studies.
Fig 1. Flow chart of study selection.
doi:10.1371/journal.pone.0160827.g001
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Table 1. Included studies.
First author (year) Design N. of patients N. of operations Material Quality
Shimizu (2015) [16] Cohort/Case series 11 11 Fascia Lata 7
Woo (2014) [17] Cohort/Case series 82 101 Fascia Lata 6
Suh (2013) [15] Cohort/Case series 47 60 Fascia Lata 7
Arajy (2012) [12] Cohort/Case series 51 69 Fascia Lata 7
Evereklioglu (2012)[18] Cohort/Case series 18 26 Fascia Lata 6
Sokol (2011) [13] Cohort/Case series - 156 Fascia Lata 6
Bilgin (2010) [14] Cohort/Case series 35 43 Fascia Lata 7
Philandrianos (2010) [19] Cohort/Case series 9 12 Fascia Lata 6
Lee (2009) [20] Cohort/Case series 63 91 Fascia Lata 6
Yoon (2009) [11] Cohort/Case series 239 324 Fascia Lata 8
Cates (2008) [21] Cohort/Case series 13 21 Fascia Lata 6
Salour (2008) [22] Cohort/Case series 10 15 Fascia Lata 6
Bagheri (2007) [23] Cohort/Case series 19 30 Fascia Lata 6
DeMartelaere (2007) [24] Cohort/Case series 25 48 Fascia Lata 6
Leibovitch(2003) [10] Cohort/Case series 9 14 Fascia Lata 6
El-Toukhy (2001) [25] Cohort/Case series 24 34 Fascia Lata 6
Wesserman (2001) [26] Cohort/Case series 43 102 Fascia Lata 6
Khwarg (1999) [27] Cohort/Case series 24 27 Fascia Lata 6
Deenstra (1996) [28] Cohort/Case series 81 81 Fascia Lata 6
Chong (2010) [29] Cohort/Case series 10 10 Mersilene 8
Hafez (2008) [30] Cohort/Case series 30 50 Mersilene 6
Salour (2008) [22] Cohort/Case series 10 16 Mersilene 6
Mehta (2005) [31] Cohort/Case series 20 32 Mersilene 6
Sharma (2003) [32] Cohort/Case series 41 71 Mersilene 7
El-Toukhy (2001) [25] Cohort/Case series 32 46 Mersilene 6
Kemp (2001) [33] Cohort/Case series 20 29 Mersilene 6
Lam (1997) [34] Cohort/Case series 10 10 Mersilene 5
Can (1996) [35] Cohort/Case series 22 23 Mersilene 6
Gabrieli (1996) [36] Cohort/Case series 14 20 Mersilene 6
Hintschich (1995) [37] Cohort/Case series 54 76 Mersilene 6
Downes (1990) [38] Cohort/Case series 15 23 Mersilene 5
Hayashi (2013) [39] Cohort/Case series 31 42 PTFE 8
Nakauchi (2013) [40] Cohort/Case series 20 27 PTFE 8
Wei (2009) [41] Cohort/Case series 96 130 PTFE 8
Wesserman (2001) [26] Cohort/Case series 43 102 PTFE 6
Steinkogler (1993) [42] Cohort/Case series 26 37 PTFE 6
Bansal (2015) [43] Cohort/Case series 25 38 Silicon 6
Kim (2015) [44] Cohort/Case series - 98 Silicon 6
Nucci (2015) [45] Cohort/Case series 22 44 Silicon 6
Razavi (2014) [46] Cohort/Case series 44 70 Silicon 6
Rizvi (2014) [47] Cohort/Case series 46 56 Silicon 6
Buttanri (2013) [48] Cohort/Case series 56 80 Silicon 6
Allen (2012) [49] Cohort/Case series 31 62 Silicon 7
Friedhofer (2012) [50] Cohort/Case series 112 141 Silicon 6
Van Sorge (2012) [51] Cohort/Case series 69 101 Silicon 7
Ali (2011) [52] Cohort/Case series 33 35 Silicon 6
Sokol (2011) [13] Cohort/Case series - 11 Silicon 6
(Continued)
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The prevalence of SSs with Fascia Lata was 87% with 95%CI (range: 80–93%). The SSs preva-
lence of Mersilene was higher: 92% with 95% CI (range 87–96%). The highest prevalence of SSs
was observedwith the procedures utilizing PTFE: 99% with 95%CI (range 98–100%) while the
prevalence of SSs found in surgeries performedwith silicon was 88%with 95% CI (83–91%).
The lower limit of 95% CI of SSs performedwith PTFE was above all the upper limits of
95% CI of SSs performedwith other materials, thus the PTFE has statistically significant higher
success rate than other materials.
Pooled cumulative incidence of Complications (Cs)
The cumulative incidence of Cs with Fascia Lata was 25% with 95%CI ranging between 14%
and 39%. For Mersilene the Cs cumulative incidence was 17% with 95%CI (range 9–27%).
Again, PTFE showed the best results, as the CS prevalence was only 5% (range 0.6–13%). Sili-
con showed a Cs rate of 15% with 95% CI (range 9–23%). PTFE has significant lower incidence
of Cs in comparison with Fascia lata but not with Mersilene and silicon.
Prevalence of single complications
Table 2 shows the single complications for each material. In surgeries performed utilizing Fas-
cia Lata, exposure keratitis was reported in 3.8% of cases (95%CI = 1.5–7.3), Lagophtalmos in
2.5% cases, asymmetry and amblyopia in 2.1% (95%CI = 0-7- 4.1), Entropion in 2% of cases,
overcorrection in 1.2% (95%CI = 0.4–2.7), and strabismus in 1.2% (95%CI = 0.3–2.8). Suture
infections occurred in 1% (95%CI = 0.5–1.6). All the remaining complications occurred in less
than 1% of surgeries.
When compared to the Fascia Lata group, surgeries performedwith Mersilene showed
higher percentages of Lagophthalmos (3,6%; 95%CI: 0,7–5,3), asymmetry (2,4%; 95%CI: 0,4–
5.1), granuloma (2.3%; 95%CI = 0.8–4.5), herniation (1.5%; 95%CI: 0.5–3.1) and suture infec-
tion (1.4%; 95%CI: 0.4–3.0). On the contrary, lower percentages of overcorrection (1%; 95%
CI = 0.4–2.7), entropion (0.7%; 95%CI = 0.1–1.7), strabismus (0.7%; 95%CI = 0.1–1.7) and
exposure keratitis (3.2%; 95%CI = 0.9–6.6) were observed.
Interventions performedwith PTFE showed higher percentages of the suture infections
(1.9%; 95%CI = 0.2–5.3) as compared to Fascia Lata, but lower incidence of all other
complications.
When compared to Fascia Lata, interventions utilizing Silicon had higher rates of herniation
(2.0%; 95%CI = 1–3.4) but lower incidence of all other complications.
Meta regression
Ameta-regression analysis for the two main outcomes (SSs and overall rate of complications)
was performed on all studies included and separately on studies evaluating Fascia Lata and
Table 1. (Continued)
First author (year) Design N. of patients N. of operations Material Quality
Lamont (2010) [53] Cohort/Case series 26 42 Silicon 6
Bernardini (2009) [54] Cohort/Case series 10 16 Silicon 6
Lee (2009) [20] Cohort/Case series 60 90 Silicon 6
Lelli (2009) [55] Cohort/Case series 33 51 Silicon 7
Fogagnolo (2008) [56] Cohort/Case series 22 22 Silicon 6
Carter (1996) [57] Cohort/Case series 35 61 Silicon 6
doi:10.1371/journal.pone.0160827.t001
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Silicone (S1 Fig). The number of studies evaluating PTFE (5) [26,39–42] and Mersilene (12)
[29,30,22,31,32,25,33–38] did not allow to perform the meta-regression in these groups. The
year of publication, the mean age of the sample, the proportion of male among patients, the
mean follow-up and the quality of the studies were used as covariates in the analysis.
The results of meta-regression of all studies included (Table 3) showed that year of publica-
tion, the proportion of male in the sample and the quality of the studies negatively correlate
with the prevalence of SSs while the mean age of the sample does not. The proportion of male
positively correlates with the rate of complications while the mean follow-up and the quality of
the study negatively correlates with overall rate of complications (ORC).
Table 2. Pooled percent prevalence of SuccessfulSurgeries (SSs) and cumulative incidence of complications for eachmaterial considered.
CI = confidence interval.
Fascia Lata Mersilene PTFE Silicon
% (95%CI) % (95%CI) % (95%CI) % (95%CI)
Succesfull Surgeries (SSs) 87 (80–93) 92 (87–96) 99 (98–100) 88 (83–91)
Tot complications (Cs) 25 (14–39) 17 (9–27) 5 (0.6–13) 15 (9–23)
Suture infection 1 (0.5–1.6) 1.4 (0.4–3.0) 1.9 (0.2–5.4) 0.6 (0.2–1.2)
Lagophthalmos 2.5 (0.7–5.3) 3.6 (0.8–8.2) 0.3 (0.0–1.2) 2.2 (0.6–4.8)
Asymmetry 2.1 (0.7–4.1) 2.4 (0.7–5.1) 1.5 (0.0–5.3) 1.6 (0.4–3.5)
Granuloma 0.5 (0.2–0.9) 2.3 (0.8–4.5) 1.2 (0.0–3.7) 1.0 (0.4–1.8)
Herniation 0.4 (0.1–0.8) 1.5 (0.5–3.1) 0.5 (0.0–1.5) 2.0 (1.0–3.4)
Overcorrection 1.2 (0.4–2.7) 1.0 (0.3–2.2) 0.3 (0.0–1.2) 0,7 (0.3–1.3)
Hypertrophic scar 0.8 (0.3–1.6) - - -
Preseptal cellulitis 0.3 (0.0–0.7) 0.8 (0.0–1.8) 0.3 (0.0–1.2) 0.6 (0.2–1.2)
Entropion 2.0 (0.8–3.6) 0.7 (0.1–1.7) 0.3 (0.0–1.2) 0.5 (0.2–1.0)
Abscess 0.4 (0.1–0.8) 0.8 (0.2–1.9) 0.3 (0.0–1.2) 0.5 (0.2–1.1)
Amblyopia 2.1 (0.0–7.3) 0.7 (0.1–1.7) 0.3 (0.0–1.2) 0.4 (0.0–0.8)
Strabismus 1.2 (0.3–2.8) 0.7 (0.1–1.7) 0.3 (0.0–1.2) 0.4 (0.0–0.8)
Exposure keratitis 3.8 (1.5–7.3) 3.2 (0.9–6.6) 0.3 (0.0–1.2) 3.0 (0.6–7.2)
doi:10.1371/journal.pone.0160827.t002
Table 3. Meta-regression for the outcomes SuccesfullSurgeries (SSs) andOveral Rate of Complications.
Successful operations All materials Fascia lata Silicon
β P β P β P
Year of publication -0.10 <0.1 1.06 <0.01 -0.60 <0.01
Mean age -0.04 0.17 0.48 <0.01 -0.67 <0.01
Male proportion -0.35 <0.01 -0.91 <0.01 -0.66 <0.01
Mean follow-up 0.00 0.85 0.09 0.01 0.14 0.01
Study quality -0.29 <0.01 -0.18 <0.01 -0.06 0.46
R2 0.24 0.63 0.35
Complications All materials Fascia lata Silicon
β P β P β P
Year of publication 0.03 0.33 0.71 <0.01 -0.32 <0.01
Mean age 0.04 0.12 0.37 <0.01 0.09 0.24
Male proportion 0.25 <0.01 -0.17 <0.01 0.27 <0.01
Mean follow-up -0.10 <0.01 0.14 <0.01 -0.42 <0.01
Study quality -0.09 <0.01 -0.32 <0.01 0.15 0.03
0.06 0.35 0.41
doi:10.1371/journal.pone.0160827.t003
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In studies evaluating Fascia, Lata (19) [10–28] the year of publication, the mean age of the
sample and the mean follow-up positively correlate with the SSs and the ORC, while the pro-
portion of males and the study quality negatively correlates with both outcomes. In studies
evaluating Silicon (17) [43–52,13, 53,54,20,55–57], the year of publication, the mean age and
the proportion of males negatively correlate with the SSs while the mean follow-up positively
correlates the SSs. The year of publication and the mean follow-up negatively correlates with
the ORC while male proportion and the quality of the studies positively correlates with ORC.
Discussion
The correction of a blepharoptosis is crucial to avoid long term visual consequences during
developmental age, such as abnormal head postures and amblyopia. In addition, the level of
satisfaction of the patient, i.e. functional and aesthetic outcomes, represents an additional chal-
lenge to the surgeon performing ptosis correction. The optimal surgical intervention should
not necessitate reoperations, should not lead to the onset of complications and would necessi-
tate the least number of follow-up visits.
In this review, we aimed at evaluating the influence that the choice of the suspensionmate-
rial, either autologous (Fascia Lata) or allogenic (mersilene, PTFE, and silicon) may have on
functional results (Successful Surgeries, SSs) and rate of complications. Our analysis showed
that the rate of successful surgeries and complications did not significantly vary among these
materials, although slight differences were observed. In fact, while patients undergoing ptosis
repair with autogenous Fascia Lata had a 90% rate of SSs in the long term (i.e. not requiring
new interventions or recurring during the follow-up period),Mersilene and PTFE seem to lead
to better outcomes, with a rate of 95 and 99% respectively. Silicon has the lowest potential as a
long lasting suspensorymaterial, with a rate of success of 79%.
The advantages and the complications of each materials, as reported in the literature ana-
lyzed, are described below.
Fascia Lata
The advantage of using Fascia Lata consists in the possibility to harvest autologous material
[26], thus minimizing the risk of rejection or extrusion of the sling as compared to allogenic
sources [57]. For these reasons, Fascia Lata has been considered the optimal material by the
majority of surgeons, especially for lid suspension procedures in children under 3 years of age
[5]. Recently, Leibovitch addressed the possibility of using Fascia Lata in newbornswith con-
genital ptosis, demonstrating and confirming the feasibility of this procedure even in younger
age groups [10]. In addition, Evereklioglu experimented a newminimally invasive ‘kite-tail’
Fascia Lata strip technique, consisting of 3 to 5 cm length of Fascia Lata graft. The first and
foremost consequence is the lower rate of complications at the surgical site compared to the
traditional technique, with the avoidance of muscle prolapse, haematoma formation and func-
tional disabilities in the early postoperative days [18]. Naugle and coworkers previously
reported a favorable outcome using Fascia Lata in two 3-year-old patients and in a 2-year-old
child affected by congenital ptosis [60]. However, despite its highest biocompatibility and the
lowest rate of sling extrusion [30,34,35], Fascia Lata is difficult to harvest in infants, and the
possibility of permanent thigh scars makes it an unattractive choice to the parents [10,33,63].
Mersilene
To obviate the lack of suitable alternatives in younger patients with blepharoptosis, novel etero-
logous materials were introduced in oculoplastic surgery by the end of the eighties. The
research was focused on finding synthetic sling materials with the same biocompatibility and
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durability of Fascia Lata, and eliminating the need to perform a double procedure at two differ-
ent surgical sites. In 1989, Downes and Collins introduced for the first time the use of Mersi-
lene mesh in blepharoptosis surgery, with success rates similar to autogenous materials [64].
Since then, Mersilene has been widely accepted as a valid alternative, being suitable even for
children under 3 years of age.
Chong [29] reported only a 10% failure rate with Mersilene mesh in infants requiring early
correction of blepharoptosis, posing new promising possibilities for younger patients and over-
coming the issue of the diffuse incapability of the ophthalmic surgeon to harvest autologous
material from a site far from his usual area of competence[25].Moreover, the use of Mersilene
is encouraged by other advantages, such as shorter surgical times and reduced number of mul-
tiple specialists within the surgical team.
Nonetheless, other studies revealed that the major complications associated with the use of
mersilene are the relatively high incidence of sling extrusion, granuloma formation [65] and
infection [36]. Only minor corneal complaints were reported that just required the use of topi-
cal lubricants.
In such cases, the use of a reversible allogenicmaterial and a minor degree of overcorrection
is advisable, especially in older patients with tearing problems or poor or absent Bell’s
phenomenon.
Our analysis revealed that the use of Mersilene Mesh, compared to other materials, leads to
higher rates of lagophthalmos (3.1%), asymmetry (2.8%) and granuloma (2.1%) but the lower
rates of suture infection (1.0%).
Polytetrafluoroethylene (PTFE)
Among the materials investigated in the present review, our analysis revealed that PTFE shows
the best results, as for percentage of successful surgeries (99%;) and the overall complication
rate (5%). Concerning the SSs PTFE is significantly better than other materials.
The major concern related to the use of PTFE is the rate of infectious complications or gran-
uloma formation. For this complication PTFE shows the highest rate in comparison with the
other materials (1.9%). Nonetheless, according to our results, PTFE shows the lowest rates for
all the other complications examined: asymmetry, granuloma, overcorrection, hypertrophic
scar, preseptal cellulitis, entropion, abscess, amblyopia, strabismus, and exposure keratitis.
Silicon
In our examination, silicon was the least successful of all synthetic materials, with a 88% rate of
successful surgeries (SSs). Silicon was first used by Tillett and Tillett in 1966 [42,66] as a pio-
neer sling material for blepharoptosis with poor levator function. Since then, silicon has been
widely used in several surgical series, reporting a recurrence rate ranging from 7% to 44%
[40,54–68].
This wide range of postoperative recurrence rates among the studies we included in the
analysis especially for siliconemight be related to the effect of different surgical designs, post-
operative follow-up periods and blepharoptosis etiologies. Particularly, compared to other
materials, silicon seems to be useful in the management of patients affected by myogenic ptosis
and poor Bell’s phenomenon (myasthenia gravis, third nerve palsy, CPEO [Chronic Progres-
sive External Ophthalmoplegia])[20]. In fact, silicon, given its wide availability and elastic
properties, results more appropriate in patients with high level of corneal exposure that
requires frequent adjustments of the sling height [6,69]. In contrast, other non-stretchable
materials, like Fascia Lata and polytetrafluoroethylene, are preferred in young children in
whom a long term solution is advisable and aesthetic outcome is essential.
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As for complications lagophtalmos and herniation were the most frequent. In the literature,
it is also reported a case of bilateral granuloma formation, probably caused by Candida or
Atypical Micobacteria, in a 5-year-old child requiring bilateral blepharoptosis surgery and mul-
tiple revisions at the surgical site [70].
Limitations
The study present some limitations. The first is the lack of a direct comparison among the dif-
ferent materials and of a measure of association for the comparison of the outcomes. The
majority of the studies take into account only one materials and do not compare outcomes
among two or more materials. Performing a networkmeta-analysis to provide associationmea-
sure would be misleading because we would compare completely different populations and
surgical equips.
The second limitation is the lack of information on the surgical technique. Different results
might be due to different techniques adopted.
Conclusion
Althoughmost studies were good quality cohort studies, the overall quality of this evidence
should be regarded as low due to their non-comparative design. PTFE shows the highest rate of
SSs, statistically significant, and the lower rate of complications. The results of this study sug-
gest that PTFE is the material with lowest recurrence rates and good cosmetic and functional
results for frontalis suspension surgery.
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